临床外科杂志 ›› 2026, Vol. 34 ›› Issue (8): 888-892.doi: 10.3969/j.issn.1005-6483.20260051

• 论著 • 上一篇    下一篇

Masquelet诱导膜技术治疗Wagner 3~4级糖尿病足的临床疗效观察:单中心病例研究

  

  1. 433000  湖北仙桃,仙桃市第一人民医院骨外科
  • 收稿日期:2026-01-16 接受日期:2026-01-16 出版日期:2026-08-20 发布日期:2026-08-20
  • 通讯作者: 许勇,Email:334193999@qq.com

Clinical efficacy of the masquelet induced membrane technique in the treatment of Wagner grade 3-4 diabetic foot:a single-center case series study

  1. Department of Orthopedic Surgery,Xiantao First People's Hospital,Hubei,Xiantao 433000,China
  • Received:2026-01-16 Accepted:2026-01-16 Online:2026-08-20 Published:2026-08-20

摘要: 目的 评估Masquelet诱导膜技术治疗Wagner 3~4级糖尿病足伴骨缺损或骨髓炎的临床疗效,并比较不同Wagner分级病人的预后差异。方法2022年1月~2024年10月接受Masquelet技术治疗的Wagner 3~4级糖尿病足病人21例,其中Wagner 3级组11例,Wagner 4级组10例。均在一期手术行彻底清创与抗生素骨水泥间隔物植入,二期于诱导膜内行自体或复合骨植骨重建。比较两组病人的保肢率、深部感染控制、骨性愈合及创面愈合情况,并记录围手术期指标及随访功能恢复情况,随访时间为12~18个月。结果 全组保肢率为 85.7%(18/21),Wagner 3级组与4级组分别为90.9%与80.0%,两组比较差异无统计学意义(P>0.05)。总体骨性愈合率为81.0%(17/21),其中Wagner 3级组为90.9%,Wagner 4级组为70.0%,两组比较差异无统计学意义(P>0.05)。骨愈合时间为(14.2±3.1)周,Wagner 3级组与Wagner 4级组比较,差异无统计学意义(P>0.05)。创面最终均愈合,整体创面愈合时间为(9.3±2.7)周。复发感染4例(19.0%),两组比较差异无统计学意义(P<0.05)。Wagner 4级组病人一期清创范围和二期植骨量均高于Wagner3级组,两组比较差异有统计学意义(P<0.05),两组住院时间、并发症及功能恢等比较,差异无统计学意义(P>0.05)。结论 Masquelet诱导膜技术在Wagner 3~4级糖尿病足中的应用安全、可行,可实现较高的感染控制率、骨性重建率及保肢率。Wagner 4级病人的部分预后指标虽呈不良趋势,但总体差异无统计学意义,提示在严格适应证选择和综合管理前提下,该技术可作为重度糖尿病足的保肢策略。

关键词: Masquelet诱导膜技术, 糖尿病足, 保肢

Abstract: Objective To evaluate the clinical efficacy of the Masquelet induced membrane technique in treating Wagner grade 3-4 diabetic foot with bone defect or osteomyelitis and compare the prognostic differences between patients with different Wagner grades.Methods Clinical data of 21 patients with Wagner grade 3-4 diabetic foot who underwent the Masquelet technique at Xiantao First People's Hospital from January 2022 to October 2024 were retrospectively analyzed,including 11 cases of Wagner grade 3 and 10 cases of Wagner grade 4.All patients underwent thorough debridement and antibiotic-loaded bone cement spacer implantation in the first-stage surgery,followed by autologous or composite bone grafting reconstruction within the induced membrane in the second stage.Limb salvage rate,deep infection control,bone healing,and wound healing were compared between the two groups.Perioperative indicators and functional recovery during follow-up were recorded,with a follow-up period of 12-18 months.Results The overall limb salvage rate was 85.7% (18/21),with 90.9% for Wagner grade 3 and 80.0% for Wagner grade 4 (P>0.05).The overall bone healing rate was 81.0% (17/21),with 90.9% in Wagner grade 3 and 70.0% in Wagner grade 4 (P>0.05).The bone healing time was (14.2±3.1) weeks,slightly shorter in grade 3 compared to grade 4 (P>0.05).All wounds ultimately healed,with an overall wound healing time of (9.3±2.7) weeks.Recurrent infection occurred in 4 cases (19.0%),with no statistically significant difference between the two groups(P<0.05).Wagner grade 4 patients had significantly larger debridement range in the first stage and greater bone graft volume in the second stage compared to grade 3 (all P<0.05),but no significant differences were observed in hospitalization duration,complications,or functional recovery(P<0.05).Conclusion The Masquelet induced membrane technique is safe and feasible for Wagner grade 3-4 diabetic foot,achieving high infection control,bone reconstruction,and limb salvage rates.Although some prognostic indicators showed a negative trend in Wagner grade 4 patients,the overall differences were not significant,suggesting that this technique can serve as an important limb salvage strategy for severe diabetic foot under strict indication selection and comprehensive management.

Key words: masquelet induced membrane technique, diabetic foot, limb salvage

[1] 汪涛, 刘坚军, 李旭, 陶悦, 王晓俊, 黎力梦. DNA损伤与糖尿病足溃疡创面炎症反应的相关性分析[J]. 临床外科杂志, 2026, 34(7): 792-796.
[2] 王峻岭 李欣 张冀北. 自体脂肪移植联合富血小板纤维蛋白用于糖尿病足修复的近期和远期效果分析[J]. 临床外科杂志, 2026, 34(3): 345-350.
[3] 郭鑫, 黄若昆. 2023国际糖尿病足工作组:糖尿病相关的足病预防与管理指南解读[J]. 临床外科杂志, 2026, 34(1): 26-29.
[4] 李静 周羿辰 衡德忠. 创面负压治疗联合骨膜牵张术治疗糖尿病足的临床研究[J]. 临床外科杂志, 2024, 32(7): 763-766.
[5] 李皓桓. 2021美国骨科医师学会临床实践指南:保肢和早期截肢解读[J]. 临床外科杂志, 2022, 30(1): 34-36.
[6] 丁文茂, 李岚, 王松山. 超声清创联合湿性疗法在糖尿病足溃疡治疗中的应用[J]. 临床外科杂志, 2021, 29(4): 382-384.
[7] 谢群, 张瑞瑞, 山超等. 人工真皮移植联合藻酸盐辅料治疗糖尿病足的疗效评估[J]. 临床外科杂志, 2019, 27(9): 813-815.
[8] 韩伟峰 王冰. 负压创面引流技术在糖尿病足治疗中的作用[J]. 临床外科杂志, 2012, 20(9): 647-649.
[9] 王金龙;徐斌;王兵. 封闭负压引流技术在糖尿病足治疗中的应用体会[J]. 临床外科杂志, 2012, 20(8): 597-598.
[10] 谷涌泉 . 糖尿病足下肢动脉闭塞性病变的外科治疗进展[J]. 临床外科杂志, 2012, 20(5): 318-318.
[11] 王冰 孟烨 韩伟峰. 糖尿病足溃疡外科治疗的临床研究[J]. 临床外科杂志, 2012, 20(3): 186-186.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 胡光俊;宋晓阳;陶军. 右美托咪定添加到罗哌卡因中对腰丛坐骨神经阻滞及镇静的影响[J]. 临床外科杂志, 2016, 24(10): 796 .
[2] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[3] 李晓辉;金太欣;邵永胜 . 升结肠回盲部肿瘤侵犯乙状结肠22例治疗体会[J]. 临床外科杂志, 2016, 24(11): 841 .
[4] 朱旭阳;朱学锋. 乳腺癌改良根治术后负压引流管的改良应用[J]. 临床外科杂志, 2016, 24(11): 867 .
[5] 李波 赵智刚 唐忠志 . 严重创伤合并创伤性凝血病的临床治疗分析 [J]. 临床外科杂志, 2016, 24(4): 302 - 302 .
[6] 张华园;高峰;董军等. 颅内多发脑膜瘤一例[J]. 临床外科杂志, 2016, 24(4): 319 .
[7] 王勇 罗文 段鑫 . 腹腔镜下全腹膜外腹股沟疝修补手术的规范化问题 [J]. 临床外科杂志, 2016, 24(4): 316 .
[8] 熊元;刘国辉;夏天等. 有限内固定结合踝关节外固定架治疗复杂开放性踝关节骨折46例[J]. 临床外科杂志, 2016, 24(5): 356 -0 .
[9] 冯勋强. 改良Devine治疗小儿隐匿性阴茎158例分析[J]. 临床外科杂志, 2016, 24(5): 379 -0 .
[10] 王婵;董传江;张路生等. 假瘤性腺性囊性膀胱炎的临床诊断与治疗[J]. 临床外科杂志, 2016, 24(5): 335 -0 .